acetylcysteine has been researched along with Depressive Disorder in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 12 (85.71) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Berk, M; Bortolasci, CC; Cotton, SM; Dean, OM; Dodd, S; Dowling, N; Gray, L; Malhi, GS; Mohebbi, M; Ng, CH; Sarris, J; Turner, A; Voigt, C; Walder, K | 1 |
| Berk, M; Bortolasci, C; Dean, OM; Dodd, S; Gray, L; Hasebe, K; Kidnapillai, S; Malhi, G; Mohebbi, M; Panizzutti, B; Spolding, B; Walder, K | 1 |
| Bloch, MH; Costa, DLC; Diniz, JB; Joaquim, MA; Miguel, EC; Pittenger, C; Requena, G; Shavitt, RG | 1 |
| Bauer, IE; Colpo, GD; Durkin, K; Green, C; Selvaraj, S; Soares, JC; Teixeira, AL; Zunta-Soares, GB | 1 |
| Berk, M; Dean, OM; Ellegaard, PK; Licht, RW; Mohebbi, M; Nielsen, CT; Nielsen, RE; Poulsen, HE | 1 |
| Fernandes, J; Gupta, GL | 1 |
| Allwang, C; Berk, M; Bush, A; Cobb, H; Cotton, SM; Dean, OM; Dodd, S; Hewitt, K; Jeavons, S; Kohlmann, K; Malhi, GS; Moss, K; Robbins, J; Schapkaitz, I; Tanious, M | 1 |
| Abelaira, HM; Bruchchen, L; Carlessi, AS; Ceretta, LB; Dos Santos, MA; Florentino, D; Matias, BI; Petronilho, F; Quevedo, J; Réus, GZ; Titus, SE; Vieira, A; Zugno, AI | 1 |
| Berk, M; Dean, OM; Dodd, S; Fernandes, BS; Malhi, GS | 1 |
| Allwang, C; Berk, M; Bush, AI; Cobb, H; Cotton, SM; Dean, O; Dodd, S; Fernandes, BS; Gama, CS; Hewitt, K; Jeavons, S; Kapczinski, F; Kohlmann, K; Malhi, GS; Schapkaitz, I | 1 |
| Fries, GR; Kapczinski, F | 1 |
| Anderson-Hunt, M; Berk, M; Bush, AI; Copolov, DL; Dean, OM; Jeavons, S; Kohlmann, K; Magalhães, PV; Malhi, GS; Schapkaitz, I | 1 |
| Choate, J; Emre, SH; Luczycki, SM; Maitta, RW; Wu, Y | 1 |
| Conley, RR; Dwivedi, Y; Faludi, G; Mondal, AC; Palkovits, M; Pandey, GN; Rizavi, HS; Sarosi, A | 1 |
2 review(s) available for acetylcysteine and Depressive Disorder
| Article | Year |
|---|---|
N-Acetylcysteine in depressive symptoms and functionality: a systematic review and meta-analysis.
Topics: Acetylcysteine; Activities of Daily Living; Depressive Disorder; Follow-Up Studies; Humans; Randomized Controlled Trials as Topic | 2016 |
Emergency ABO-incompatible liver transplant secondary to fulminant hepatic failure: outcome, role of TPE and review of the literature.
Topics: ABO Blood-Group System; Acetaminophen; Acetylcysteine; Adult; Antibodies, Monoclonal, Murine-Derived; Antidepressive Agents; Biliary Tract Surgical Procedures; Blood Group Incompatibility; Cholestasis; Combined Modality Therapy; Depressive Disorder; Emergencies; Female; Graft Rejection; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Liver Failure, Acute; Liver Function Tests; Plasma Exchange; Postoperative Complications; Rituximab; Stents; Suicide, Attempted | 2012 |
7 trial(s) available for acetylcysteine and Depressive Disorder
| Article | Year |
|---|---|
Interleukin-6 and total antioxidant capacity levels following
Topics: Acetylcysteine; Antioxidants; Bipolar Disorder; Case-Control Studies; Depressive Disorder; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Energy Metabolism; Female; Free Radical Scavengers; Humans; Inflammation; Interleukin-6; Male; Mitochondria; Oxidative Stress; Placebos; Treatment Outcome | 2020 |
Adjunctive N-acetylcysteine in depression: exploration of interleukin-6, C-reactive protein and brain-derived neurotrophic factor.
Topics: Acetylcysteine; Adult; Aged; Antidepressive Agents; Biomarkers; Brain-Derived Neurotrophic Factor; C-Reactive Protein; Depressive Disorder; Female; Humans; Interleukin-6; Male; Middle Aged; Psychiatric Status Rating Scales; Treatment Outcome; Young Adult | 2017 |
Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Anxiety Disorders; Comorbidity; Depressive Disorder; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Psychometrics; Selective Serotonin Reuptake Inhibitors; Young Adult | 2017 |
A Double-Blind, Randomized, Placebo-Controlled Study of Aspirin and N-Acetylcysteine as Adjunctive Treatments for Bipolar Depression.
Topics: Acetylcysteine; Adult; Aged; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bayes Theorem; Bipolar Disorder; Chemotherapy, Adjuvant; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Oxidative Stress; Treatment Outcome | 2018 |
The efficacy of adjunctive N-acetylcysteine in acute bipolar depression: A randomized placebo-controlled study.
Topics: Acetylcysteine; Adult; Antidepressive Agents; Bipolar Disorder; Brief Psychiatric Rating Scale; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Young Adult | 2019 |
The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial.
Topics: Acetylcysteine; Adult; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Depression; Depressive Disorder; Female; Free Radical Scavengers; Humans; Male; Middle Aged; Mood Disorders; Quality of Life; Severity of Illness Index; Treatment Outcome | 2011 |
N-acetylcysteine for major depressive episodes in bipolar disorder.
Topics: Acetylcysteine; Adult; Antidepressive Agents; Bipolar Disorder; Chemotherapy, Adjuvant; Depressive Disorder; Female; Humans; Male; Psychiatric Status Rating Scales; Treatment Outcome | 2011 |
5 other study(ies) available for acetylcysteine and Depressive Disorder
| Article | Year |
|---|---|
N-acetylcysteine attenuates neuroinflammation associated depressive behavior induced by chronic unpredictable mild stress in rat.
Topics: Acetylcysteine; Animals; Antidepressive Agents; Behavior, Animal; Cytokines; Depression; Depressive Disorder; Disease Models, Animal; Fluoxetine; Hippocampus; Inflammation; Male; Neuroimmunomodulation; Rats; Rats, Wistar; Serotonin; Stress, Physiological; Stress, Psychological | 2019 |
Deserves a hearing? A case report of remitting tinnitus with N-acetyl cysteine.
Topics: Acetylcysteine; Depressive Disorder; Drug Repositioning; Female; Free Radical Scavengers; Glutathione; Hearing; Humans; Middle Aged; Oxidative Stress; Tinnitus; Treatment Outcome | 2013 |
Antioxidant treatment ameliorates experimental diabetes-induced depressive-like behaviour and reduces oxidative stress in brain and pancreas.
Topics: Acetylcysteine; Animals; Antioxidants; Behavior, Animal; Brain; Deferoxamine; Depressive Disorder; Diabetes Mellitus, Experimental; Free Radical Scavengers; Lipid Peroxidation; Male; Oxidative Stress; Pancreas; Rats; Rats, Wistar; Siderophores | 2016 |
N-acetylcysteine as a mitochondrial enhancer: a new class of psychoactive drugs?
Topics: Acetylcysteine; Antidepressive Agents; Bipolar Disorder; Depressive Disorder; Female; Humans; Male | 2011 |
Differential and brain region-specific regulation of Rap-1 and Epac in depressed suicide victims.
Topics: Acetylcysteine; Adult; Aged; Brain; Brain Chemistry; Cerebellum; Depressive Disorder; Erythromycin; Female; Gene Expression Regulation; Hippocampus; Humans; Male; Middle Aged; Neuronal Plasticity; Prefrontal Cortex; rap1 GTP-Binding Proteins; RNA, Messenger; Suicide; Tissue Distribution | 2006 |